secwatch.observer — SEC 8-K summary
======================================

Issuer:     CYPHERPUNK TECHNOLOGIES INC. (CYPH)
CIK:        0001509745
Form:       8-K
Filed at:   2025-09-11T23:59:59+00:00
Accession:  0001410578-25-002072
Event type: regulatory
Sentiment:  negative
Materiality: 0.65
Item codes: 3.01
LLM model:  deepseek-v4-flash:cloud@v2

Leap Therapeutics gets Nasdaq bid price extension to March 9, 2026
------------------------------------------------------------------

- Nasdaq granted additional 180-day compliance period until March 9, 2026, for minimum $1.00 bid price.
- Initial 180-day period ended Sept. 8, 2025; company met all other listing standards except bid price.
- Company may implement a reverse stock split to regain compliance.
- No assurance of regaining compliance; delisting could follow if not cured by March 9, 2026.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1509745/000141057825002072/0001410578-25-002072-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1509745/000141057825002072/tm2525891d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001410578-25-002072

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer